Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT
Andrée-Laure Herr(European Organisation for Rare Diseases), Vanderson Rocha(Fundação Pró-Sangue Hemocentro de São Paulo), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Nabil Kabbara(Université Paris Cité), Franco Locatelli(Bambino Gesù Children's Hospital), Pierre Teira(Université de Montréal), Chiara Messina(University of Insubria), Samir Nabhan(Hôpital Saint-Louis), Éliane Gluckman(Assistance Publique – Hôpitaux de Paris), Karin Tiedemann(Royal Children's Hospital), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Irina Ionescu(European Organisation for Rare Diseases), Arjan C. Lankester(Leiden University Medical Center), Yves Bertrand(Université Claude Bernard Lyon 1), Jean‐Pierre Jouet(Hôpital Claude Huriez), Wagnara Chaves(European Organisation for Rare Diseases), Carmem Bonfim(Universidade Federal do Paraná)
Cited by 41
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738